- Home
- GNK vs ANNX Comparison
GNK vs ANNX Comparison
Compare GNK & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | ANNX |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.7M | 972.5M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNK | ANNX |
|---|---|---|
| Price | $24.44 | $5.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $19.00 | $16.50 |
| AVG Volume (30 Days) | 286.8K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $21.15 | N/A |
| Revenue Next Year | $1.41 | $16,320.74 |
| P/E Ratio | $117.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.66 | $1.85 |
| 52 Week High | $27.25 | $7.18 |
Technical Indicators
Market Signals| Indicator | GNK | ANNX |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 30.95 |
| Support Level | $22.40 | $4.79 |
| Resistance Level | N/A | $5.07 |
| Average True Range (ATR) | 0.90 | 0.29 |
| MACD | -0.11 | -0.09 |
| Stochastic Oscillator | 18.80 | 3.90 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.